# Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

> **NCT07206121** · NA · RECRUITING · sponsor: **Innoblative Designs, Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Breast Cancer
- Breast-conserving Surgery
- Breast Cancer - Infiltrating Ductal Carcinoma
- ER/PR+Her2neu
- Grade I, II, III

## Interventions

- **DEVICE:** Radiofrequency ablation alone
- **DEVICE:** Radiofrequency ablation Electrosurgical Device

## Key facts

- **NCT ID:** NCT07206121
- **Lead sponsor:** Innoblative Designs, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-10
- **Primary completion:** 2027-02-06
- **Final completion:** 2032-02-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07206121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07206121, "Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07206121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*